ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: A slight increase of SCD by 8-Cl-Ado was also detected in HL60 cells but the overall toxicity in combination with the TKIs was lower as compared to the BCR::ABL1-positive CML cell lines (increase of 19% to 23–32%).